Jim O’Neill is the chair of Chatham House. He is currently the vice-chair of the Northern Powerhouse Partnership and a member of Shelter Social Housing Commission.
Since leaving government in September 2016, having been Commercial Secretary to the Treasury, Jim moved to the crossbenches of the House of Lords.
He led an independent review into antimicrobial resistance (AMR) for David Cameron from late 2014 to September 2016, and remains focused on this challenge.
From 2013 to 2014, he chaired the Cities Growth Commission in the UK, which formed the impetus for the government’s policy on devolution as well as the concept of the Northern Powerhouse.
Jim worked for Goldman Sachs from 1995 until April 2013, spending most of his time there as chief economist.
Before 1995, he worked for Swiss Bank Corporation, Marine Midland Bank and Bank of America, having started in the City in 1982.
Jim is also the creator of the acronym BRIC and has conducted much research about these and other emerging economies. He has published various books on the topic, and in early 2014 made a documentary series for the BBC entitled MINT: The Next Economic Giants.
He writes frequently on these and many other international economic and financial topics for leading international media.
Jim is one of the founding trustees of the UK educational charity, SHINE, and has served on many educational foundation boards, as well as having served on the boards of a number of international organisations and think tanks.
He also served as a non-executive director of Manchester United before it returned to private ownership in 2005.
Jim earned BA and MA degrees in economics from Sheffield University in 1978 and a PhD from the University of Surrey in 1982. He has honorary degrees from the Institute of Education, University of London, for his educational philanthropy, from City University for his services to banking and finance, and from Sheffield University in recognition of his contribution to international economics.
Jim is an honorary fellow of the Faculty of Public Health and a fellow of the Academy of Social Sciences.